Diagnostic value of vascular endothelial growth factor for malignant pleural effusion: A Meta-analysis

doi:10.3877/cma.j.issn.1674-6902.2017.01.007

Abstract

Abstract:

Objective

To asses the diagnostic value of vascular endothelial growth factor (VEGF) in malignant pleural effusion by Meta-analysis.

Methods

We not only searched Best Evidence, Cochrane library, PubMed, CBM, CNKI , VIP, Wanfang Data et al but also checked online (www.google.cn; www.baidu.com) and traced literature to gather the relevant research literature on VEGF for the diagnosis of malignant pleural effusion from January 2000 to May 2016. Then we used Meta-Disc 1.4 and RevMan 5.3 software for data analysis to evaluate the diagnostic value of VEGF in malignant pleural effusion by calculating the pooled sensitivity, specificity, the likelihood ratio(LR), diagnostic odds ratios (DOR) and conducting summary receiver operating characteristic curve(SROC curve).

Results

Totally 747 articles were searched and finally 10 were included with sample size of 893 cases, including 468 cases of malignant pleural effusion and 425 cases of benign pleural effusion. The summary estimates for VEGF in the diagnosis of MPE were: sensitivity 0.72(95% CI 0.67, 0.76), specificity0.80 (95% CI 0.75, 0.83), positive likelihood ratio 3.81(95% CI 2.40, 6.06), negative likelihood ratio 0.37(95% CI 0.28, 0.48), diagnostic odds ratio 12.79(95% CI 6.33, 25.84) and the SROC area under the curve(AUC) 0.8384.

Conclusions

VEGF in pleural effusion has potential diagnostic value with advanced sensitivity and specificity and it can be used as adjunct tool for non-invasive diagnosis of malignant pleural effusion.

Key words: Vascular endothelial growth factor, Pleural effusion, Diagnosis, Meta-analysis

Xianmeng Chen, Gengyun Sun. Diagnostic value of vascular endothelial growth factor for malignant pleural effusion: A Meta-analysis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(01): 29-34.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfbjbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6902.2017.01.007

https://zhfbjbzz.cma-cmc.com.cn/EN/Y2017/V10/I01/29

Figures/Tables 8

References 20

1	孙耕耘. 胸腔积液的诊断与治疗进展[J]. 临床肺科杂志，2005, 10(2): 141-143.
2	Kaifi JT, Toth JW, Gusani NJ, et al. Multidisciplinary management of malignant pleural effusion[J]. J Surg Oncol, 2012, 105(7): 731-738.
3	Cheng D, Liang B, Li YH. Application of mmp-7 and mmp-10 in assisting the diagnosis of malignant pleural effusion[J]. Asian Pac J Cancer Prev, 2012, 13(2): 505-509.
4	Hooper C, Lee YC, Maskell N, et al. Investigation of a unilateral pleural effusion in adults: British thoracic society pleural disease guideline 2010[J]. Thorax, 2010, 65 Suppl 2: 4-17.
5	Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors[J]. Mol Biol Cell, 1992, 3(2): 211-220.
6	邱志雄，史轩丰，薛飞，等. 血管内皮生长因子、基质金属蛋白酶-2对良恶性胸腔积液的诊断价值[J]. 临床肺科杂志，2012, 17(7): 1279-1280.
7	赵洪焕，韩素桂，刘启为，等. 胸水MIC-1、VEGF、CEA对良恶性胸腔积液的鉴别价值[J]. 标记免疫分析与临床，2013, 20(6): 476-477.
8	高俊珍，吕福祯，申丽华，等. 胸腔积液中血管内皮生长因子的检测及临床意义[J]. 中华结核和呼吸杂志，2005, 28(6): 424-425.
9	Shu J, Sun G, Liu H, et al. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions[J]. Acta Oncologica, 2007, 46(7): 1004-1011.
10	Xue K, Xiong S, Xiong W. Clinical value of vascular endothelial growth factor combined with Interferon-γ in diagnosing malignant pleural effusion and tuberculous pleural effusion[J]. J Huazhong Univ Sci Technolog Med Sci, 2007, 27(5): 495-497.
11	Bao QL, Li J, Sun W, et al. Diagnostic Utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin[J]. Jpn J Clin Oncol, 2014, 44(12): 1198-1205.
12	Duysinx BC, Corhay JL, Hubin L, et al. Diagnostic value of interleukine-6，transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions[J]. Respir Med, 2008, 102(12): 1708-1714.
13	Fiorelli A, Vicidomini G, Di Domenico M, et al. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications[J]. Interact Cardiovasc Thorac Surg, 2011, 12(3): 420-424.
14	Gu Y, Zhang M, Li GH, et al. Diagnostic values of vascular endothelial growth factor and epidermal growth factor receptor for benign and malignant hydrothorax[J]. Chin Med J (Engl), 2015, 128(3): 305-309.
15	Zhou W, Bai M, Jin Y. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions[J]. Int J Tuberc Lung Dis, 2009, 13(3): 381-386.
16	张燕，孙耕耘. 恶性胸腔积液的临床诊断及治疗进展[J]. 2013, 6(1): 81-84.
17	Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusion[J]. Chest, 2004, 126(6): 1757-1763.
18	Lee JH, Chang JC. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer[J]. Chest, 2005, 128(4): 2298-2303.
19	Hamed EA, El-noweihi AM, Mohamed AZ, et al. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions[J]. Respirology, 2004, 9(1): 81-86.
20	Yano S, Shinohara H, Herbst RS, et al. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells[J]. Am J Pathol, 2000, 157(6): 1893-1903.

作　者	国家	研究对象	金标准	患者数	截断值(Pg/ml)	TP	FP	FN	TN	检测方法
邱志雄^[6]	China	连续	病理	80	487.8	31	10	9	30	ELISA
赵洪焕^[7]	China	连续	病理	92	250.0	54	7	3	28	ELISA
高俊珍^[8]	China	连续	病理	65	237.7	24	9	8	24	ELISA
Shu J^[9]	China	连续	病理	81	925.9	15	2	17	47	ELISA
Xue K ^[10]	China	连续	病理	87	945.7	34	7	8	38	ELISA
Bao QL^[11]	China	连续	病理	136	2 650.0	31	3	24	57	Real time-PCR
Duysinx BC^[12]	France	连续	病理	103	382.0	44	18	20	21	ELISA
Fiorelli A^[13]	Italy	连续	病理	79	652.0	31	5	18	25	ELISA
Gu Y^[14]	China	连续	病理	65	297.1	28	1	7	29	ELISA
Zhou W^[15]	China	联系	病理	128	1 600.0	44	25	18	39	ELISA

作　者	国家	研究对象	金标准	患者数	截断值(Pg/ml)	TP	FP	FN	TN	检测方法
邱志雄^[6]	China	连续	病理	80	487.8	31	10	9	30	ELISA
赵洪焕^[7]	China	连续	病理	92	250.0	54	7	3	28	ELISA
高俊珍^[8]	China	连续	病理	65	237.7	24	9	8	24	ELISA
Shu J^[9]	China	连续	病理	81	925.9	15	2	17	47	ELISA
Xue K ^[10]	China	连续	病理	87	945.7	34	7	8	38	ELISA
Bao QL^[11]	China	连续	病理	136	2 650.0	31	3	24	57	Real time-PCR
Duysinx BC^[12]	France	连续	病理	103	382.0	44	18	20	21	ELISA
Fiorelli A^[13]	Italy	连续	病理	79	652.0	31	5	18	25	ELISA
Gu Y^[14]	China	连续	病理	65	297.1	28	1	7	29	ELISA
Zhou W^[15]	China	联系	病理	128	1 600.0	44	25	18	39	ELISA

纳入研究	QUADAS条目
纳入研究	1	2	3	4	5	6	7	8	9	10	11	12	13	14
邱志雄^[6]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
赵洪焕^[7]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
高俊珍^[8]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Shu J^[9]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Xue K ^[10]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Bao QL^[11]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Duysinx BC^[12]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Fiorelli A^[13]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Gu Y^[14]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Zhou W^[15]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N

纳入研究	QUADAS条目
纳入研究	1	2	3	4	5	6	7	8	9	10	11	12	13	14
邱志雄^[6]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
赵洪焕^[7]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
高俊珍^[8]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Shu J^[9]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Xue K ^[10]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Bao QL^[11]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Duysinx BC^[12]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Fiorelli A^[13]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Gu Y^[14]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N
Zhou W^[15]	Y	Y	Y	Y	Y	Y	Y	Y	N	U	Y	U	Y	N

[1]	Shuihua Yang, Guidan He, Guican Qin, Mengfeng Liang, Yanhe Luo, Xueqin Li, Juansong Tang. Echocardioimagedata characteristics of fetal isolated total anomalous pulmonary venous connection and application of high definition flow imaging and spatio-temporal image correlation [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1061-1067.
[2]	Heng Lyu, Licong Dong, Haiqin Xie, Zhuofei Zhao, Li Liu, Desheng Sun. CT-ultrasound comparison for evaluating missed diagnosis of focal liver lesions by ultrasound: a single-center cross-sectional quality control survey [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 712-716.
[3]	Siping Zhang, Wei Liu, Pengcheng Ma. Therapeutic effects of lower extremity mild varus alignment after total knee arthroplasty [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 808-817.
[4]	Wanglin Luo, Chuanjun Yang, Guoxing Xu, Jianguo Yu, Weidong Sun, Wenjuan Yan, Zhi Feng. Meta analysis on implantation of different grafting materials in open wedge high tibial osteotomy [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 818-826.
[5]	Peijie Li, Yongjie Qiao, Haoqiang Zhang, Jiankang Zeng, Fei Tan, Jiahuan Li, Jing Wang, Shenghu Zhou. Progress in diagnosis and treatment of periprosthetic infection with negative bacterial culture [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 827-833.
[6]	Yi He, Dongsheng Yu. Advances in diagnosis and treatment of dislocation injury of young permanent teeth [J]. Chinese Journal of Stomatological Research(Electronic Edition), 2023, 17(06): 400-406.
[7]	Xiongxiong Li, Chan Zhou, Ting Xu, Yu Ren, Jin Shang. Metastasis rate of newly diagnosed ductal carcinoma in situ with microinvasive axillary lymph nodes: A Meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 466-474.
[8]	Zaibo Zhang, Bingyu Wang, Zhikai Jiao, Bibo Tan. Risk factors for lower extremity deep venous thrombosis after gastric cancer surgery: A Meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 475-480.
[9]	Xu Peng, Yongfu Shao, Duo Li, Rui Zhou, Zhenming Xing. Diagnosis and surgical treatment of hepatocolon flexure [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 108-110.
[10]	Ruiqi Gu, Hongsheng Fang, Guoxiang Cai. Application and progress of circulating tumor DNA detection technology in the diagnosis and treatment of colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 453-459.
[11]	Bing Lan, Huaiming Wang, Hui Wang, Bo Ma. Research progress on locally advanced colon cancer with bladder invasion [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 505-511.
[12]	Hongjie Yang, Zhichun Zhang, Yi Sun. Study progress in the diagnosis of lymph node metastasis of rectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 512-518.
[13]	Lili Zhao, Kuixiang Wang, Xiaochong Zhang, Zhiyuan Li. Diagnostic value of ESR to C-Reactive protein ratio in diagnosis of periprosthetic joint Infection [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(06): 351-355.
[14]	Xiu Wang, Yiguo Wang. Efficacy and safety of ustekinumab in treating perianal fistulizing Crohn′s disease: a meta-analysis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 514-519.
[15]	Tian Li, Hong Xu, Heliang Liu. Progress in research of pneumoconiosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 900-905.

Please choose a citation manager

Content to export